Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 1 · 100%

Progression‐free survival · people with metastatic CRC

FOLFIRI + targeted therapy leads to lower progression‐free survival compared with FOLFIRI (high certainty).

1 finding from 1 review

Second‐line systemic therapy for metastatic colorectal cancer 2017 · Cochrane Headline outcomes only
HR 0.78 [0.71, 0.87]
6 studies · 3335 participants
High